Nexentis Technologies Inc.

NXTS Nasdaq CIK: 0001789192

Company Information

Industry Agricultural Chemicals
SIC Code 2870
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation NV
Business Address 156 FIFTH AVENUE 10TH FLOOR, NEW YORK, NY, 10010-7751
Mailing Address 156 FIFTH AVENUE 10TH FLOOR, NEW YORK, NY, 10010-7751
Phone 972544561349
Fiscal Year End 1231
EIN 264684680

Financial Overview

FY2025

$16.01M
Stockholders' Equity
$-3.54
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) March 23, 2026 View on SEC
3 Initial insider ownership report March 23, 2026 View on SEC
8-K Current report of material events March 17, 2026 View on SEC
DEF 14A Definitive proxy statement March 12, 2026 View on SEC
8-K Current report of material events February 26, 2026 View on SEC
8-K Current report of material events February 25, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 24, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 12, 2026 View on SEC

Annual Reports

10-K March 31, 2026
  • Developing AI-driven cancer drug discovery platform MITOLINE™
  • Active solar energy project development in Italy, Poland, and Germany
View Analysis

Material Events

8-K Strategy Change March 17, 2026
High Impact
  • Nexentis sold its 98% majority stake in Save Foods Ltd. to Voice Assist, Inc.
  • Acquired a significant 19.99% ownership stake in Voice Assist through newly issued shares.
View Analysis
8-K Strategy Change January 13, 2026
High Impact
  • N2OFF, Inc. sold its majority (98%) stake in subsidiary Save Foods Ltd. to Voice Assist, Inc.
  • N2OFF will receive 19.99% of Voice Assist's common stock upon deal closure.
View Analysis

Related Companies

Companies in the same industry (SIC: 2870)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.